Australia Bariatric Surgery Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

Australia represents a mature, high-spending segment of the wider Asia-Pacific bariatric surgery market, which was valued at around USD 913.53 million in 2022 and continues to expand. Within Australia, sleeve gastrectomy has become the dominant procedure, followed by Roux-en-Y gastric bypass, while gastric banding volumes have fallen sharply over the past decade. Procedure volumes and per-case device consumption both contribute to the market's roughly USD 0.15 billion valuation in 2025.

• •Sleeve gastrectomy is now the most commonly performed bariatric procedure in Australia.
• •The broader Asia-Pacific bariatric surgery market reached approximately USD 913.53 million in 2022.
• •Public hospital data show that bariatric surgery in Australia carries substantial per-case costs, much of it attributable to device use and operating time.

Obesity affects a large and growing share of Australian adults, generating sustained clinical demand for both primary and revisional bariatric procedures. Strong evidence of long-term remission of type 2 diabetes and improvements in cardiovascular and metabolic risk has shifted bariatric surgery from a last-resort option to a mainstream therapeutic intervention. Reimbursement support from Medicare and private insurers, combined with broader access through accredited public hospitals, is removing historic financial barriers for patients.

• •Australia has one of the highest adult obesity rates among developed economies, with prevalence continuing to rise.
• •Clinical guidelines increasingly recognise bariatric surgery as a standard-of-care option for patients with class II/III obesity and metabolic comorbidities.
• •Private health insurer coverage and Medicare item numbers encourage uptake in both public and private settings.

By procedure, the market is led by sleeve gastrectomy, with Roux-en-Y gastric bypass as the second most common operation, followed by gastric balloon procedures and other less invasive endoscopic options; gastric banding has declined to a small share. By device, assisting devices such as staplers, energy devices, trocars and suturing systems account for the bulk of spend, alongside implantable devices like gastric bands and intragastric balloons. Geographically, procedure volumes are concentrated in New South Wales and Victoria, where the largest public bariatric units and private hospital networks are based.

• •Assisting and closure devices (staplers, energy generators, suturing tools) represent the largest device sub-segment.
• •Sleeve gastrectomy typically accounts for more than half of all bariatric procedures performed in Australia.
• •New South Wales and Victoria together perform the majority of publicly funded bariatric cases.

What are the recent trends and outlook?

Procedure volumes are forecast to grow steadily through 2030, supported by population-based projections that flag a widening gap between demand for bariatric surgery and public system capacity. Minimally invasive and endoscopic techniques, including robotic-assisted sleeve gastrectomy and endoluminal procedures, are gaining traction as surgeons seek to shorten recovery times and reduce complication rates. Population-based research also highlights persistent inequities in access, particularly for patients in regional areas and those reliant on the public system, which is likely to drive policy debate over the coming decade.

• •Demand-supply modelling suggests Australian public bariatric capacity will need to expand materially to keep pace with obesity prevalence.
• •Robotic-assisted and endoscopic bariatric techniques are an emerging area of clinical investment.
• •Reducing geographic and socioeconomic inequities in access is expected to be a key policy and market focus through 2030.